BWAY

Brainsway Ltd.

9.68

Top Statistics
Market Cap 184 M Forward PE 96.80 Revenue Growth 27.80 %
Current Ratio 4.70 Trailing PE 121.00 Earnings Growth 0.00 %
Profit Margins 1.67 % Peg Ratio Dividend Yield 0.00 %
Enterprice / EBITA 138.78 Enterprise / Revenue 6.67 Price To Sales Trailing12 Months 5.06
Profitability
Profit Margins 1.67 % Operating Margins 5.86 %
Balance Sheet
Total Cash 47 M Total Cash Per Share 1.59 Total Debt
Total Debt To Equity Current Ratio 4.70 Book Value Per Share 1.25
All Measures
Short Ratio 33.00 % Message Board Id finmb_34280817 Shares Short Prior Month 28986
Return On Equity 0.0144 City Jerusalem Uuid 4b7576e5-11f7-3ea0-a827-d2fc22b2b272
Previous Close 9.71 First Trade Date Epoch Utc 1 B Book Value 1.25
Beta 0.3740 Volume 22952 Price To Book 7.74
Fifty Two Week Low 4.61 Total Cash Per Share 1.59 Total Revenue 36 M
Shares Short Previous Month Date 1 B Target Median Price 13.20 Max Age 86400
Recommendation Mean 1.25 Sand P52 Week Change 0.3133 Operating Margins 5.86 %
Target Mean Price 13.72 Net Income To Common 608000 Short Percent Of Float 0.0033
Implied Shares Outstanding 16 M Trailing Peg Ratio None Last Fiscal Year End 1 B
Average Daily Volume10 Day 66690 Average Volume10days 66690 Total Cash 47 M
Next Fiscal Year End 1 B Revenue Per Share 2.15 Ebitda Margins 4.81 %
Trailing PE 121.00 Date Short Interest 1 B Most Recent Quarter 1 B
Regular Market Previous Close 9.71 Target Low Price 12.50 Gmt Off Set Milliseconds -18000000
Fifty Day Average 9.55 Open 9.79 Free Cashflow 3 M
Dividend Yield 0.00 % Return On Assets 0.0073 Time Zone Short Name EST
Trailing Eps 0.0800 Day Low 9.57 Address1 Bynet Building
Shares Outstanding 18 M Price Hint 2 Target High Price 16.00
Website https://www.brainsway.com 52 Week Change 0.5439 Average Volume 90029
Forward Eps 0.1000 Recommendation Key strong_buy Compensation As Of Epoch Date 1 B
Quick Ratio 424.10 % Is_sp_500 False Regular Market Day High 9.79
Profit Margins 1.67 % Fifty Two Week High 10.98 Day High 9.79
Shares Short 37590 Regular Market Open 9.79 Industry Key medical-devices
Earnings Growth 0.00 % Enterprise To Revenue 6.67 Revenue Growth 27.80 %
Shares Percent Shares Out 0.0023 Operating Cashflow 8 M Currency USD
Time Zone Full Name America/New_York Market Cap 184 M Is_nasdaq_100 False
Zip 9777518 Quote Type EQUITY Industry Medical Devices
Long Name BrainsWay Ltd. Regular Market Day Low 9.57 Held Percent Institutions 0.1922
Current Price 9.68 Address2 3rd Floor 19 Hartum Street Har Hotzvim Enterprise To Ebitda 138.78
Financial Currency USD Current Ratio 4.70 Gross Margins 74.82 %
Industry Disp Medical Devices Number Of Analyst Opinions 4 Country Israel
Float Shares 22 M Two Hundred Day Average 7.14 Ir Website http://www.brainsway.com/Brainsway/Templates/ShowPage.asp?DBID=1&LNGID=1&TMID=84&FID=540
Enterprise Value 243 M Price To Sales Trailing12 Months 5.06 Forward PE 96.80
Regular Market Volume 22952 Ebitda 1 M Exchange NGM
Go to Yahoo Finance Go to Seeking Alpha
BrainsWay Ltd.

develops and sells noninvasive neurostimulation treatments for mental health disorders in the United States, East Asia, and internationally.

It offers Deep Transcranial Magnetic Stimulation platform technology for the treatment of major depressive disorders, anxious depression, obsessive-compulsive disorders, smoking addiction, bipolar disorders, post traumatic stress disorders, schizophrenia, Alzheimer's disease, autism, chronic pain, multiple sclerosis, post stroke rehabilitation, and Parkinson's diseases.

The company serves doctors, hospitals, and medical centers in the field of psychiatry.

BrainsWay Ltd.

was founded in 2003 and is headquartered in Jerusalem, Israel.